Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10544188
Inhibitor of apoptosis protein (IAP) antagonists
granted -
US 10543221
Beta-lactamase inhibitors, formulations, and uses thereof
granted -
US 10537560
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 10538513
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
granted -
US 10537535
Histone deacetylase inhibitors
granted -
US 10532986
Cyclic compound acting as PDE4 inhibitor
granted -
US 10525101
Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factor
granted -
US 10526330
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 10526346
Histone deacetylase inhibitors
granted -
US 10519133
Vinyl compounds as FGFR and VEGFR inhibitors
granted -
US 10519153
Fused imidazo-piperidine JAK inhibitors
granted -
US 10512673
Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease
granted -
US 10512637
Use of inhibitor of cystine-glutamate transporter
granted -
US 10508122
Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
granted -
US 10508106
Bicyclic BET bromodomain inhibitors and uses thereof
granted -
US 10501439
DNA-PK inhibitors
granted -
US 10501444
Inhibitors of influenza virus replication, application methods and uses thereof
granted -
US 10500194
Covalent small molecule DCN1 inhibitors and therapeutic methods using the same
granted -
US 10494442
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
granted -
US 10494364
Cathepsin K inhibitors and application thereof
granted -
US 10493077
Fused imidazo-piperidine JAK inhibitor compound
granted -
US 10485796
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted -
US 10485803
Pyrimidine compounds as JAK kinase inhibitors
granted -
US 10485844
Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
granted